メニュー
Request a Quote
お問い合わせ
JP
financial-consideration1920x640
Whitepaper

Maximizing returns in biotherapeutic investment: Financial considerations for expression systems

Picking the right expression system to produce your biotherapeutic can cost you more than just product quality and serious consideration of all factors is crucial. This decision will not only impact on quality and quantity of biotherapeutic produced, but also on the overall production cost-effectiveness of your process.

In this whitepaper, we examine the key factors you should be considering during expression system selection that will help you optimize resource allocation, reduce risk, and maximize the potential for commercial success.

Covering areas in:

  • Balancing higher titers and diminishing returns
  • Savings gained with stable pools in early-stage development
  • The cost-yield equation
  • Sustainability processes to optimize efficiency 

The CHOSOURCE Platform is available for research, clinical, diagnostic, and commercialization applications, including services, under specific licenses from Revvity.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Maximizing returns in biotherapeutic investment: Financial considerations for expression systems

Download Whitepaper